Untitled
Previous | Next

Back to BW50
Home Page >>

The BusinessWeek 50 Ranking

48

McKesson

MCKESSON, THE world’s biggest drug distributor, came up with a cure for a splitting legal headache last year. A $960 million settlement ended a suit stemming from a massive 1999 earnings restatement that contributed to the San Francisco company’s ending in the red in fiscal 2001. Now, McKesson’s focus is squarely back on distributing medicines to pharmacies and hospitals. That’s sweet relief, as growth in generic drug sales has bolstered margins in this notoriously lowmargin business. Also helping get McKesson back in the black: sales of its new, higher-margin healthcare management software.

Company Info

2005 Rank

237

GET MORE
COMPANY INFO

MCK

Market Value
$ Million

16,563.8

Total Return
$ Million
(1-yr.) 45.7
(3-yr.) 107.3
2005 Sales
$ Billion

85.9

Sales Growth
$ Million
(1-yr.) 10
(3-yr.) 16.0
Long-Term Growth Est. %

13.5

Net income
$ Million

776.0

Net Income Growth
$ Million
(1-yr.) NM
(3-yr.) 14.8
Net Margin %*

0.9

Return on Inv. Capital (%)*

11.3

Share Price
12-Mo. Hi/Lo

55/35

P/E Ratio

22

Industry Health Care Equipment & Services
CORPORATE WEB SITE
More in S&P 500 Companies Scoreboard >
*Trailing 12 months
Company data as of 2/28/06 provided by Standard & Poor's Compustat

John H. Hammergren

John H. Hammergren, 46

CEO since 2001




More BW Stories on McKesson